title: [Liver X receptors as targets in inflammatory or leukemic plasmacytoid dendritic cells].
authors.affiliation: Université Bourgogne Franche-Comté, Inserm, EFS BFC, UMR1098, Interactions hôte-greffon-tumeur, LabEX LipSTIC, 1, boulevard A Fleming, 25020 Besançon, France.
authors.forename: Adam
authors.initials: A
authors.lastname: Ceroi
authors.affiliation: Université Bourgogne Franche-Comté, Inserm, U1231, Lipides Nutrition Cancer, LabEX LipSTIC, Dijon, France.
authors.forename: David
authors.initials: D
authors.lastname: Masson
authors.affiliation: Université Bourgogne Franche-Comté, Inserm, EFS BFC, UMR1098, Interactions hôte-greffon-tumeur, LabEX LipSTIC, 1, boulevard A Fleming, 25020 Besançon, France.
authors.forename: Francine
authors.initials: F
authors.lastname: Garnache-Ottou
authors.affiliation: Université Bourgogne Franche-Comté, Inserm, EFS BFC, UMR1098, Interactions hôte-greffon-tumeur, LabEX LipSTIC, 1, boulevard A Fleming, 25020 Besançon, France.
authors.forename: Philippe
authors.initials: P
authors.lastname: Saas
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D063646:Carcinogenesis / Q000378:metabolism / Q000473:pathology; D002784:Cholesterol / Q000378:metabolism; D003713:Dendritic Cells / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D007249:Inflammation / Q000276:immunology / Q000628:therapy*; D007938:Leukemia / Q000276:immunology / Q000628:therapy*; D000071518:Liver X Receptors / Q000037:antagonists & inhibitors / Q000502:physiology*; D058990:Molecular Targeted Therapy / Q000379:methods*
chemical_list: D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D000071518:Liver X Receptors; D002784:Cholesterol